JILL NEWMAN: Open Payments
NPI 1952843625 · EASLEY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 15 payments from 8 companies in 2025. Trend: 2023 $233 · 2024 $298 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Novo Nordisk Inc | 2 | $33 |
| Exact Sciences Corporation | 2 | $32 |
| Lilly USA, LLC | 2 | $29 |
| Alkermes, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, MOUNJARO, LYBALVI, The Cologuard Plus Collection Kit, Rybelsus, Ozempic, GARDASIL 9.
Industry payments across SC — which companies pay providers there.
